Sort
64,565 grants matching “drug discovery”
University of Pittsburgh Microphysiology Systems Database Center
$1,074,147Mark E Schurdak · University Of Pittsburgh At Pittsburgh · U24 · FY2019 · TR
Regulatory landscape of the human genome: comparative and evolutionary analysis.
$1,073,873Ivan Ovcharenko · National Library Of Medicine · ZIA · FY2021 · LM
Rhythmicity and Synchrony in the Basal Ganglia
$1,073,826Dalton James Surmeier · Northwestern University At Chicago · P50 · FY2017 · NS
XENOBIOTICS AND ALLERGIC INFLAMMATION
$1,073,393University Of California Los Angeles · U19 · FY2000 · AI
Plasma proteomics in CHS and population biology
$1,073,392Bruce M Psaty · University Of Washington · R01 · FY2022 · HL
Center for Genomics and Society
$1,072,936Gail E Henderson · Univ Of North Carolina Chapel Hill · P50 · FY2007 · HG
Development of a drug discovery platform for human islets
$1,072,731Benjamin M Buehrer · Zen-Bio, Inc. · R44 · FY2014 · DK
Maintenance of Models of Human Hemophilia and VWD
$1,072,618Timothy Charles Nichols · Univ Of North Carolina Chapel Hill · R24 · FY2015 · HL
Center Based Initiative #2 (Florida)
$1,072,582Patrick Robert Griffin · Scripps Research Institute, The · U54 · FY2010 · MH
Vaccines and Therapeutics for Nipah and Hendra virus
$1,072,517Christopher Broder · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2012 · AI
Neurxtem Neural Organoid Human Platform Development for Substance and Opioid Use Disorders
$1,071,864Rene Anand · Neurxstem, Inc. · R44 · FY2021 · DA
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY
$1,071,656Harvard University (Medical School) · U19 · FY2002 · CA
Computational Molecular Pathology Research for Cancer Diagnostics and Biomarkers
$1,071,429Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Translating genomic discoveries to improved outcomes for high risk acute leukemia
$1,071,276Charles G. Mullighan · St. Jude Children'S Research Hospital · R35 · FY2017 · CA
Cellular Mechanisms Of Xenobiotic Transport
$1,071,017David Miller · Environmental Health Sciences · Z01 · FY2007 · ES
Multiscale Mathematical Modeling of Cancer Progression
$1,070,597Vito Quaranta · Vanderbilt University · U54 · FY2012 · CA
Pharmacology and drug development core
$1,070,539Diane Heck · Univ Of Med/Dent Nj-R W Johnson Med Sch · U54 · FY2012 · AR
COMBINATORIAL CREATION OF NEW ANTICANCER AGENTS
$1,070,422University Of Minnesota Twin Cities · P01 · FY2001 · CA
Orally-Bioavailable Peroxynitrite Decomposition Catalyst Targeting Post-Surgical Pain
$1,070,335Scott L Dax · Cersci Therapeutics, Inc. · R44 · FY2018 · DA
Multi-Center Study of Pancreatic Cancer Etiology
$1,070,318Margaret T Mandelson · Kaiser Foundation Health Plan Of Washington · R01 · FY2008 · CA
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
$1,070,303David A Stoltz · University Of Iowa · R01 · FY2017 · HL
TUMOR SENSITIZATION TO PURINE ANALOGS BY E.COLI PNP
$1,070,294Southern Research Institute · U19 · FY2003 · CA
Depletion of Dendritic Cells by Immunotoxin as Therapy for Myocardial Infarction
$1,070,291Michael W Fanger · Celdara Medical, Llc · R44 · FY2012 · HL
Novel Sensor Integrated Proteome on Chip (SPOC) platform for evaluating kinetic parameters of protein interactions in high throughput
$1,070,227Bharath Takulapalli · Spoc Proteomics Inc. · R44 · FY2023 · TR
NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR)
$1,070,007Xiang-Qun Xie · University Of Pittsburgh At Pittsburgh · P30 · FY2016 · DA